DOCSLIB.ORG

AP-1 Transrepressing Retinoic Acid Does Not Deplete Coactivators Or AP-1 Monomers but May Target Speci®C Jun Or Fos Containing Dimers

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
AP-1 Transrepressing Retinoic Acid Does Not Deplete Coactivators Or AP-1 Monomers but May Target Speci®C Jun Or Fos Containing Dimers Oncogene (2002) 21, 2181 ± 2190 ã 2002 Nature Publishing Group All rights reserved 0950 ± 9232/02 $25.00 www.nature.com/onc AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target speci®c Jun or Fos containing dimers Kazumi Suzukawa1 and Nancy H Colburn*,1 1Gene Regulation Section, Basic Research Laboratory, National Cancer Institute at Frederick, Frederick, Maryland, MD 21702- 1201, USA Retinoic acid (RA) inhibits tumor promotion in many Introduction models in vivo and in vitro, among them mouse epidermal JB6 cells. RA treatment suppresses 12-O-tetradecanoyl- Carcinogenesis is a multistep process consisting of phorbol-13-acetate (TPA) induced AP-1 activity, an initiation, promotion and progression (Fearon and activity that is required for transformation of JB6 P+ Vogelstein, 1990; Klein, 1981). Regulators of responsible cells. The molecular mechanism of AP-1 transrepression signaling pathways for each stage are potential targets by retinoids is unclear, especially as related to inhibition for cancer prevention (Boutwell, 1989; Colburn et al., of transformation. Overexpression of AP-1 components 1979, 1982). A causal relationship between tumor did not rescue TPA induced AP-1 activation nor did a promoter-induced neoplastic transformation and activa- GST pull down experiment implicate direct binding, thus tion of transcription factor AP-1 has been demonstrated rendering unlikely both a Jun/Fos-RA-RAR direct in mouse and human cell progression models (Bernstein interaction and a Jun/Fos sequestration mechanism. and Colburn, 1989; Dong et al., 1994; Li et al., 1998) and Overexpression of p300, SRC-1 or pCAF did not in a dominant negative c-jun transgenic mouse (Young et abrogate AP-1 suppression by RA, thus arguing against al., 1999). In the JB6 mouse epidermal cell clonal coactivator competition. Overexpression of the corepres- variants, AP-1 transactivation is induced by 12-O- sor silencing mediator for retinoic acid and thyroid tetradecanoylphorbol-13-acetate (TPA) in transforma- hormone receptors (SMRT) suppressed AP-1 activity. tion sensitive but not in resistant cells (Bernstein and However, SMRT but not RA inhibited cJun transactiva- Colburn, 1989). TPA induced cell transformation is tion, suggesting SMRT does not mediate RA transre- blocked by AP-1 inhibitors such as retinoids, glucocorti- pression. RA treatment also did not block TPA induced coids, and the dominant negative cJun (TAM67) (Dong ERK phosphorylation, Jun/Fos family protein expression et al., 1994; Li et al., 1996, 1997). Retinoic acid (RA) is except for cFos, or DNA binding of the AP-1 complex. eective in inhibiting papilloma formation in mouse skin The transcriptional activities of full-length JunB and and transformation of mouse epidermal JB6 cells full-length Fra-1, but not the transactivation domain (Colburn et al., 1981; Li et al., 1996; Verma and fusions, were increased by TPA treatment and sup- Boutwell, 1977). RA induces dierentiation of keratino- pressed by RA. Since these full-length fusions have bzip cytes and suppresses tumor phenotype in several models domains, the results suggest that JunB and/or Fra-1- (Bollag and Holdener, 1992; Chen et al., 1995; Fuchs and containing dimers may constitute one target of RA for Green, 1980). RA can also cause a reversible phenotypic transrepression of AP-1. suppression of the TPA-transformed JB6 cell line RT101 Oncogene (2002) 21, 2181 ± 2190. DOI: 10.1038/sj/ (Dong et al., 1995). onc/1205281 The biological eects of RA are mediated by its receptors (RARs) in the nucleus. The RARs belong to Keywords: AP-1; JB6 cells; retinoic acid; transrepres- a large superfamily of ligand-inducible transcription sion; GAL4 transactivation assay factors that include vitamin D and thyroid hormone receptors. The retinoid receptors consist of two subunits, RARs (a, b, g) and RXRs (a, b, g) (Chambon, 1996). It has been well documented that liganded nuclear receptors including RAR inhibit AP-1 activation (Fisher and Voorhees, 1996; Li et al., 1996, 1997; Pfahl, 1993; Resche-Rigon and Gronemeyer, 1998; Saatcioglu et al., 1994; Schule and Evans, 1991). Transactivation of target genes through the *Correspondence: NH Colburn, Gene Regulation Section, Basic RARE sequence is functionally dissociated from Research Laboratory Building 560 Room 21 ± 89, National Cancer transrepression of AP-1 (Bollag and Holdener, 1992; Institute at Frederick, PO Box B, Frederick, Maryland, MD 21702- Chen et al., 1995; Fanjul et al., 1994; Fuchs and Green, 1201, USA; E-mail: [email protected] Received 22 August 2001; revised 14 December 2001; accepted 19 1980; Li et al., 1996). Inhibition of tumor promotion December 2001 by RA appears to be mediated by blocking AP-1 AP-1 transrepression by retinoic acid in JB6 cells K Suzukawa and NH Colburn 2182 activation, not by activating retinoic acid response element (RARE)- dependent transcription (Li et al., 1996). Mouse JB6 cells express only RAR g and a, not RAR b, and the tumor promotion inhibiting activity has been attributed to the RAR g (Rudd et al., 1993). RAR g is functionally predominant for transrepression in keratinocytes (Goyette et al., 2000). The precise mechanism of transrepression of AP-1 by RA is not clear. Three mechanisms have been suggested. The ®rst is direct interaction between Jun or Fos proteins and liganded RAR (Pfahl, 1993). The second is competition between liganded RAR and Jun or Fos proteins to bind transcriptional coactivators (Kamei et al., 1996; Lee et al., 1998). The third is inhibition of cJun N- terminal kinase (JNK) (Caelles et al., 1997; Lee et al., 1999). The silencing mediator for retinoic acid and thyroid hormone receptors (SMRT) was identi®ed as a corepressor which interacts with unliganded RAR. The interaction between SMRT and RAR is destabi- lized by ligand (Chen and Evans, 1995). SMRT mediates the repressive eect of unliganded nuclear Figure 1 Transrepression of TPA induced AP-1 activity by RA. RA represses TPA induced AP-1 activity in a dose dependent receptors through the recruitment of histone deacety- manner. JB6 P(+) cells were transfected with 0.4 mg of AP-1- lase complexes (Nagy et al., 1997). SMRT also luciferase reporter construct in a 24 well plate. The next day, the suppresses other transcription factors (e.g. AP-1 SRF, cells were exposed to DMSO or TPA (10 ng/ml)+RA (in various NFkB, and Oct-1) (Kakizawa et al., 2000; Lee et al., concentrations as indicated) in 0.2% FBS+EMEM for 18 h. All 2000). Therefore, there is the possibility that RA experiments were performed in triplicate, and standard error of the mean is indicated. The data are shown as mean+s.d. Three treatment recruits SMRT from RAR to AP-1 com- independent experiments showed similar results plexes. The results presented here render unlikely the previously suggested mechanisms as well as recruitment of corepressor SMRT. Instead, RA appears to target RA (Figure 2). When cJun, Fra-1, Fra-2, or cFos was JunB and/or Fra-1-containing dimers. expressed, the AP-1 activation level with TPA+RA was similar to the solvent control level. Furthermore, a GST pull down assay using GST-retinoic acid receptor g (the functionally predominant RAR in JB6 cells) did Results not detect ligand dependent interaction with AP-1 components of a JB6 nuclear extract, while RXR a was RA transrepresses TPA induced AP-1 activation pulled down ligand independently as expected (data The concentrations of RA that inhibit TPA induced not shown). These results suggest that direct interac- transformation of JB6 cells (Dong et al., 1994), also tion of liganded RAR with Jun or Fos proteins is inhibit TPA induced AP-1 activation (Figure 1). Dose unlikely to contribute to AP-1 transrepression. dependent suppression by RA was observed at concentrations lower than 1076 M, with higher con- Concentration of coactivator is not limiting for centrations showing no greater suppression. transrepression It has been suggested that the amount of available No rescue of AP-1 activity from transrepression by jun or p300/CBP or SRC-1 can be limiting when AP-1 and fos overexpression RAR compete for binding to the coactivator (Kamei et If RAR inhibits AP-1 by direct interaction with Jun or al., 1996; Lee et al., 1998). We asked whether any of Fos proteins to sequester them, overexpression of the these coactivators is limiting for AP-1 activity in RA sequestered AP-1 component should cancel the inhibi- treated cells. Overexpression of coactivator p300 or tion. A luciferase assay of AP-1 activation in cells SRC-1 increased both basal and TPA induced AP-1 cotransfected with Jun or Fos expression constructs activity. However, neither of them reversed transre- was performed. Overexpression of JunD or JunB raised pression by RA (Figure 3), nor did expression of ASC- the basal level and prevented further induction of AP-1 2 (not shown) reverse transrepression. by TPA. Expression of cFos substantially increased Overexpression of pCAF (Figure 3) inhibited AP-1 basal AP-1 activity and TPA treatment produced a activation, suggesting pCAF is not involved in the further increase. Overexpression of cJun, Fra-1, Fra-2 coactivator complex of AP-1 in this context. To or cFos enhanced both basal and TPA induced levels determine whether transrepression between RAR and of AP-1 but failed to abrogate AP-1 transrepression by AP-1 is mutual, endogenous RAR activity was Oncogene AP-1 transrepression by retinoic acid in JB6 cells K Suzukawa and NH Colburn 2183 Figure 2 Overexpression of Jun or Fos proteins did not rescue AP-1 activity. Each AP-1 component or pcDNA3.1 as a control DNA was cotransfected with AP-1 reporter construct. JB6 P (+) cells were exposed to 0.1% DMSO or TPA+RA for 18 h. Triplicate samples were run for each condition.
Load more

Recommended publications
  • REVIEW Signal Transduction, Cell Cycle Regulatory, and Anti
    Leukemia (1999) 13, 1109–1166 1999 Stockton Press All rights reserved 0887-6924/99 $12.00 http://www.stockton-press.co.uk/leu REVIEW Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs WL Blalock1, C Weinstein-Oppenheimer1,2, F Chang1, PE Hoyle1, X-Y Wang3, PA Algate4, RA Franklin1,5, SM Oberhaus1,5, LS Steelman1 and JA McCubrey1,5 1Department of Microbiology and Immunology, 5Leo Jenkins Cancer Center, East Carolina University School of Medicine Greenville, NC, USA; 2Escuela de Quı´mica y Farmacia, Facultad de Medicina, Universidad de Valparaiso, Valparaiso, Chile; 3Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, MN, USA; and 4Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Over the past decade, there has been an exponential increase growth factor), Flt-L (the ligand for the flt2/3 receptor), erythro- in our knowledge of how cytokines regulate signal transduc- poietin (EPO), and others affect the growth and differentiation tion, cell cycle progression, differentiation and apoptosis. Research has focused on different biochemical and genetic of these early hematopoietic precursor cells into cells of the 1–4 aspects of these processes. Initially, cytokines were identified myeloid, lymphoid and erythroid lineages (Table 1). This by clonogenic assays and purified by biochemical techniques. review will concentrate on IL-3 since much of the knowledge This soon led to the molecular cloning of the genes encoding of how cytokines affect cell growth, signal transduction, and the cytokines and their cognate receptors.
    [Show full text]
  • Retinoic Acid Signaling and Neuronal Differentiation
    Cell. Mol. Life Sci. (2015) 72:1559–1576 DOI 10.1007/s00018-014-1815-9 Cellular and Molecular Life Sciences REVIEW Retinoic acid signaling and neuronal differentiation Amanda Janesick • Stephanie Cherie Wu • Bruce Blumberg Received: 23 October 2014 / Revised: 15 December 2014 / Accepted: 19 December 2014 / Published online: 6 January 2015 Ó Springer Basel 2015 Abstract The identification of neurological symptoms cell cycle exit downstream of RA will be critical for our caused by vitamin A deficiency pointed to a critical, early understanding of how to target tumor differentiation. developmental role of vitamin A and its metabolite, reti- Overall, elucidating the molecular details of RAR-regu- noic acid (RA). The ability of RA to induce post-mitotic, lated neurogenesis will be decisive for developing and neural phenotypes in various stem cells, in vitro, served as understanding neural proliferation–differentiation switches early evidence that RA is involved in the switch between throughout development. proliferation and differentiation. In vivo studies have expanded this ‘‘opposing signal’’ model, and the number of Keywords Neurogenesis Á Retinoic acid receptor Á primary neurons an embryo develops is now known to Proliferation-differentiation switch depend critically on the levels and spatial distribution of RA. The proneural and neurogenic transcription factors that control the exit of neural progenitors from the cell Introduction cycle and allow primary neurons to develop are partly elucidated, but the downstream effectors of RA receptor The role of retinoic acid (RA) in neurogenesis has been (RAR) signaling (many of which are putative cell cycle known indirectly for as long as haliver (halibut) and cod liver regulators) remain largely unidentified.
    [Show full text]
  • The Activator Protein-1 Transcription Factor in Respiratory Epithelium Carcinogenesis
    Subject Review The Activator Protein-1 Transcription Factor in Respiratory Epithelium Carcinogenesis Michalis V. Karamouzis,1 Panagiotis A. Konstantinopoulos,1,2 and Athanasios G. Papavassiliou1 1Department of Biological Chemistry, Medical School, University of Athens, Athens, Greece and 2Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts Abstract Much of the current anticancer research effort is focused on Respiratory epithelium cancers are the leading cause cell-surface receptors and their cognate upstream molecules of cancer-related death worldwide. The multistep natural because they provide the easiest route for drugs to affect history of carcinogenesis can be considered as a cellular behavior, whereas agents acting at the level of gradual accumulation of genetic and epigenetic transcription need to invade the nucleus. However, the aberrations, resulting in the deregulation of cellular therapeutic effect of surface receptor manipulation might be homeostasis. Growing evidence suggests that cross- considered less than specific because their actions are talk between membrane and nuclear receptor signaling modulated by complex interacting downstream signal trans- pathways along with the activator protein-1 (AP-1) duction pathways. A pivotal transcription factor during cascade and its cofactor network represent a pivotal respiratory epithelium carcinogenesis is activator protein-1 molecular circuitry participating directly or indirectly in (AP-1). AP-1–regulated genes include important modulators of respiratory epithelium carcinogenesis. The crucial role invasion and metastasis, proliferation, differentiation, and of AP-1 transcription factor renders it an appealing survival as well as genes associated with hypoxia and target of future nuclear-directed anticancer therapeutic angiogenesis (7). Nuclear-directed therapeutic strategies might and chemoprevention approaches.
    [Show full text]
  • Signaling by Retinoic Acid in Embryonic and Adult Hematopoiesis
    J. Dev. Biol. 2014, 2, 18-33; doi:10.3390/jdb2010018 OPEN ACCESS Journal of Developmental Biology ISSN 2221-3759 www.mdpi.com/journal/jdb/ Review Signaling by Retinoic Acid in Embryonic and Adult Hematopoiesis Elena Cano †, Laura Ariza †, Ramón Muñoz-Chápuli and Rita Carmona * Department of Animal Biology, Faculty of Science, University of Málaga, E29071 Málaga, Spain; E-Mails: [email protected] (E.C.); [email protected] (L.A.); [email protected] (R.M.-C.) † These authors contributed equally to this paper. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +34-952-134-135; Fax: +34-952-131-668. Received: 3 February 2014; in revised form: 5 March 2014 / Accepted: 6 March 2014 / Published: 17 March 2014 Abstract: Embryonic and adult hematopoiesis are both finely regulated by a number of signaling mechanisms. In the mammalian embryo, short-term and long-term hematopoietic stem cells (HSC) arise from a subset of endothelial cells which constitute the hemogenic endothelium. These HSC expand and give rise to all the lineages of blood cells in the fetal liver, first, and in the bone marrow from the end of the gestation and throughout the adult life. The retinoic acid (RA) signaling system, acting through the family of nuclear retinoic acid receptors (RARs and RXRs), is involved in multiple steps of the hematopoietic development, and also in the regulation of the differentiation of some myeloid lineages in adults. In humans, the importance of this RA-mediated control is dramatically illustrated by the pathogeny of acute promyelocytic leukemia, a disease produced by a chromosomal rearrangement fusing the RAR gene with other genes.
    [Show full text]
  • Pathway Development Via Retinoid X Receptor Vitamin a Enhances In
    Vitamin A Enhances in Vitro Th2 Development Via Retinoid X Receptor Pathway This information is current as Charles B. Stephensen, Reuven Rasooly, Xiaowen Jiang, of September 24, 2021. Michael A. Ceddia, Casey T. Weaver, Roshantha A. S. Chandraratna and R. Patterson Bucy J Immunol 2002; 168:4495-4503; ; doi: 10.4049/jimmunol.168.9.4495 http://www.jimmunol.org/content/168/9/4495 Downloaded from References This article cites 40 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/168/9/4495.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2002 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Vitamin A Enhances in Vitro Th2 Development Via Retinoid X Receptor Pathway1 Charles B. Stephensen,2* Reuven Rasooly,* Xiaowen Jiang,* Michael A. Ceddia,3* Casey T. Weaver,† Roshantha A. S. Chandraratna,‡ and R. Patterson Bucy† Vitamin A deficiency diminishes Th2-mediated Ab responses, and high-level dietary vitamin A or treatment with the vitamin A metabolite retinoic acid (RA) enhances such responses.
    [Show full text]
  • Signal Transduction and the Ets Family of Transcription Factors
    Oncogene (2000) 19, 6503 ± 6513 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc Signal transduction and the Ets family of transcription factors John S Yordy1 and Robin C Muise-Helmericks*,1,2 1Center for Molecular and Structural Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, SC 29403, USA; 2Department of Cell Biology and Anatomy, Medical University of South Carolina, Charleston, South Carolina, SC 29403, USA Cellular responses to environmental stimuli are con- expression required for cellular growth, dierentiation trolled by a series of signaling cascades that transduce and survival. One group of downstream eectors of extracellular signals from ligand-activated cell surface these signaling pathways is the Ets family of transcrip- receptors to the nucleus. Although most pathways were tion factors. Ets family members can also be initially thought to be linear, it has become apparent that considered upstream eectors of signal transduction there is a dynamic interplay between signaling pathways pathways controlling the expression of a number of that result in the complex pattern of cell-type speci®c signaling components including both receptor tyrosine responses required for proliferation, dierentiation and kinases and intermediate signaling molecules. survival. One group of nuclear eectors of these The Ets family of transcription factors is de®ned by signaling pathways are the Ets family of transcription a conserved winged helix ± turn ± helix DNA binding factors, directing cytoplasmic signals to the control of domain (Papas et al., 1989; Wasylyk et al., 1993; gene expression. This family is de®ned by a highly Werner et al., 1995).
    [Show full text]
  • Peroxisome Proliferator-Activated Receptor ; Is Highly Expressed In
    Imaging, Diagnosis, Prognosis Peroxisome Proliferator-Activated Receptor ; Is Highly Expressed in Pancreatic Cancer and Is Associated With Shorter Overall Survival Times Glen Kristiansen,1Juliane Jacob,1Ann-Christin Buckendahl,1Robert Gru« tzmann,3 Ingo Alldinger,3 Bence Sipos,4 Gu« nter Klo« ppel,4 Marcus Bahra,2 Jan M. Langrehr,2 Peter Neuhaus,2 Manfred Dietel,1and Christian Pilarsky3 Abstract Purpose: Peroxisome proliferator-activated receptor g (PPARg) is a ligand-activated transcrip- tion factor that has been implicated in carcinogenesis and progression of various solid tumors, including pancreatic carcinoma.We aimed to clarify the expression patterns of PPARg in pancre- atic ductal carcinomas and to correlate these to clinicopathologic variables, including patient survival. Experimental Design: Array-based expression profiling of 19 microdissected carcinomas and 14 normal ductal epithelia was conducted. Additionally,Western blots of pancreatic cancer cell lines and paraffinized tissue of 129 pancreatic carcinomas were immunostained for PPARg.For statistical analysis, Fisher’s exact test, m2 test for trends, correlation analysis, Kaplan-Meier analysis, and Cox’s regression were applied. Results: Expression profiles showed a strong overexpression of PPARg mRNA (change fold, 6.9; P = 0.04). Immunohistochemically, PPARg expression was seen in 71.3% of pancreatic cancer cases. PPARg expression correlated positively to higher pTstages and higher tumor grade. Survival analysis showed a significant prognostic value for PPARg, which was found to be independent in the clinically important subgroup of node-negative tumors. Conclusions: PPARg is commonly up-regulated in pancreatic ductal adenocarcinoma and might be a prognostic marker in this disease. Both findings corroborate the importance of PPARg in tumor progression of pancreatic cancer.
    [Show full text]
  • Quantitative Analysis of NF-B Transactivation Specificity Using A
    Quantitative Analysis of NF-#B Transactivation Specificity Using a Yeast-Based Functional Assay The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Sharma, Vasundhara, Jennifer J. Jordan, Yari Ciribilli, Michael A. Resnick, Alessandra Bisio, and Alberto Inga. “Quantitative Analysis of NF-κB Transactivation Specificity Using a Yeast-Based Functional Assay.” Edited by Sue Cotterill. PLOS ONE 10, no. 7 (July 6, 2015): e0130170. As Published http://dx.doi.org/10.1371/journal.pone.0130170 Publisher Public Library of Science Version Final published version Citable link http://hdl.handle.net/1721.1/99881 Terms of Use Creative Commons Attribution Detailed Terms http://creativecommons.org/licenses/by/4.0/ RESEARCH ARTICLE Quantitative Analysis of NF-κB Transactivation Specificity Using a Yeast- Based Functional Assay Vasundhara Sharma1, Jennifer J. Jordan1¤, Yari Ciribilli1, Michael A. Resnick2, Alessandra Bisio1‡*, Alberto Inga1‡* 1 Laboratory of Transcriptional Networks, Centre for Integrative Biology (CIBIO), University of Trento, Trento, Italy, 2 Chromosome Stability Group; National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States of America a11111 ¤ Current address: Department of Biological Engineering, MIT, Boston, MA, USA ‡ These authors are co-last authors on this work. * [email protected] (AB); [email protected] (AI) Abstract κ OPEN ACCESS The NF- B transcription factor family plays a central role in innate immunity and inflamma- tion processes and is frequently dysregulated in cancer. We developed an NF-κB functional Citation: Sharma V, Jordan JJ, Ciribilli Y, Resnick κ MA, Bisio A, Inga A (2015) Quantitative Analysis of assay in yeast to investigate the following issues: transactivation specificity of NF- B pro- NF-κB Transactivation Specificity Using a Yeast- teins acting as homodimers or heterodimers; correlation between transactivation capacity Based Functional Assay.
    [Show full text]
  • ETS1, Nfkb and AP1 Synergistically Transactivate the Human GM ± CSF Promoter
    Oncogene (1997) 14, 2845 ± 2855 1997 Stockton Press All rights reserved 0950 ± 9232/97 $12.00 ETS1, NFkB and AP1 synergistically transactivate the human GM ± CSF promoter Ross S Thomas1, Martin J Tymms1, Leigh H McKinlay1, M Frances Shannon2, Arun Seth3 and Ismarl Kola1 1Molecular Genetics and Development Group, Institute of Reproduction and Development, Monash University, Melbourne 3168, Australia; 2Division of Human Immunology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide 5000, Australia; 3Department of Pathology, University of Toronto/Women's College Hospital, Toronto, Ontario, Canada Activation of helper T cells results in coordinate Activating signals ultimately result in cellular prolifera- expression of a number of cytokines involved in tion, and transcriptional induction and secretion of a dierentiation, proliferation and activation of the number of cytokines including IL-2 (interleukin-2), IL-3, haematopoietic system. Granulocyte-macrophage colony IFNg (interferon-gamma) and GM ± CSF (granulocyte- stimulating factor (GM ± CSF) is one such cytokine, macrophage colony-stimulating factor) (Stanley et al., whose increased expression results mostly from increases 1985; Miyajima et al., 1988; Arai et al., 1990). These in transcription. Cis-acting elements with NFkB, AP1 cytokines direct the eector functions of various cell and ETS-like binding motifs have been identi®ed in the types involved in an immune response, including B cells, promoter region of the GM ± CSF gene, and are macrophages, mast cells, eosinophils and neutrophils. important or essential for transcriptional activity follow- GM ± CSF expression in activated T cells is ing T cell activation. ETS1 is a transcription factor of regulated by two mechanisms.
    [Show full text]
  • The Histone Acetylase PCAF Is a Nuclear Receptor Coactivator
    Downloaded from genesdev.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press The histone acetylase PCAF is a nuclear receptor coactivator Jorge C.G. Blanco,1,4 Saverio Minucci,1 Jianming Lu,1 Xiang-Jiao Yang,1 Kristen K. Walker,3 Hongwu Chen,3 Ronald M. Evans,2,3 Yoshihiro Nakatani,1 and Keiko Ozato1,5 1Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland 20892-2753 USA; 2Howard Hughes Medical Institute; 3The Salk Institute for Biological Studies, La Jolla, California 92037 USA Whereas the histone acetylase PCAF has been suggested to be part of a coactivator complex mediating transcriptional activation by the nuclear hormone receptors, the physical and functional interactions between nuclear receptors and PCAF have remained unclear. Our efforts to clarify these relationships have revealed two novel properties of nuclear receptors. First, we demonstrate that the RXR/RAR heterodimer directly recruits PCAF from mammalian cell extracts in a ligand-dependent manner and that increased expression of PCAF leads to enhanced retinoid-responsive transcription. Second, we demonstrate that, in vitro, PCAF directly associates with the DNA-binding domain of nuclear receptors, independently of p300/CBP binding, therefore defining a novel cofactor interaction surface. Furthermore, our results show that dissociation of corepressors enables ligand-dependent PCAF binding to the receptors. This observation illuminates how a ligand-dependent receptor function can be propagated to regions outside the ligand-binding domain itself. On the basis of these observations, we suggest that PCAF may play a more central role in nuclear receptor function than previously anticipated.
    [Show full text]
  • Retinoic Acid-Related Orphan Receptor Rorβ, Circadian Rhythm Abnormalities and Tumorigenesis (Review)
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 35: 1493-1500, 2015 Retinoic acid-related orphan receptor RORβ, circadian rhythm abnormalities and tumorigenesis (Review) SHUJIONG FENG1, SONG XU1, ZHENZHEN WEN1 and YONGLIANG ZHU1,2 1Laboratory of Gastroenterology, The Second Affiliated Hospital of Zhejiang University, School of Medicine; 2Cancer Institute and Education Ministry Key Laboratory of Cancer Prevention and Intervention, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China Received August 8, 2014; Accepted March 12, 2015 DOI: 10.3892/ijmm.2015.2155 Abstract. Nuclear receptors are a superfamily of transcription and have important physiological functions in cell develop- factors including the steroid hormone receptors, non-steroid ment and differentiation, circadian rhythm, metabolism and hormone receptors and the orphan nuclear receptor family. immune regulation. NRs consist of three components: the Retinoic acid-related orphan receptor (ROR)β, as a member of steroid hormone receptors, non-steroid hormone receptors the orphan nuclear receptor family, plays an important regula- and the orphan nuclear receptor family. Steroid and non- tory role in the maintenance of a variety of physiological and steroid hormone receptors have specific ligands, including pathological processes. RORβ has been determined to act as steroid hormones, thyroid hormones, retinoic acids and fatty an osteogenic repressor in regulating bone formation, and is acids. Ligands for orphan NRs have not yet been determined. involved in regulating circadian rhythm. The findings of recent Retinoic acid-related orphan receptors (RORs), also known studies concerning the association between tumorigenesis as nuclear receptor subfamily 1 group F members (NR1F), and circadian rhythm have shown that an aberrant circadian are specified by gene sequences, which are homologous to rhythm may promote tumorigenesis and tumor progression.
    [Show full text]
  • Cooperative Interaction Between Retinoic Acid Receptor-A and Estrogen Receptor in Breast Cancer
    Downloaded from genesdev.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press Cooperative interaction between retinoic acid receptor-a and estrogen receptor in breast cancer Caryn S. Ross-Innes,1 Rory Stark,2 Kelly A. Holmes,1 Dominic Schmidt,1 Christiana Spyrou,1 Roslin Russell,2 Charlie E. Massie,1 Sarah L. Vowler,2 Matthew Eldridge,2 and Jason S. Carroll1,3 1Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 0RE, United Kingdom; 2Bioinformatics Core, Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 0RE, United Kingdom Retinoic acid receptor-a (RARa) is a known estrogen target gene in breast cancer cells. The consequence of RARa induction by estrogen was previously unknown. We now show that RARa is required for efficient estrogen receptor-a (ER)-mediated transcription and cell proliferation. RARa can interact with ER-binding sites, but this occurs in an ER-dependent manner, providing a novel role for RARa that is independent of its classic role. We show, on a genome-wide scale, that RARa and ER can co-occupy regulatory regions together within the chromatin. This transcriptionally active co-occupancy and dependency occurs when exposed to the predominant breast cancer hormone, estrogen—an interaction that is promoted by the estrogen–ER induction of RARa. These findings implicate RARa as an essential component of the ER complex, potentially by maintaining ER–cofactor interactions, and suggest that different nuclear receptors can cooperate for effective transcriptional activity in breast cancer cells. [Keywords: Breast cancer; estrogen receptor; retinoic acid receptor-a; transcription; chromatin] Supplemental material is available at http://www.genesdev.org.
    [Show full text]